IMMP 6-K: A$4.6M French R&D tax incentive received

Rhea-AI Filing Summary

Immutep Limited furnished a Form 6-K noting it received an A$4.6 million research and development tax incentive from the French Government. This inflow reflects government support tied to the company’s R&D activities.

The update is administrative in nature but adds cash to the business, as disclosed in the exhibit titled “Immutep Receives A$4.6 million R&D Tax Incentive from French Government.”

Insights

Biotech finance analyst

A$4.6M French R&D incentive adds cash; administrative update.

Immutep reported receipt of an A$4.6 million R&D tax incentive from the French Government. Such incentives typically reimburse eligible research spending, providing cash without equity issuance. The filing’s core content is the amount and source of the incentive.

While this improves liquidity, the magnitude and runway impact depend on overall cash burn and budgets, which are not detailed in the excerpt. Subsequent filings may provide additional context on cash balances and R&D plans.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Date as November 03, 2025

Commission File Number 001-35428

IMMUTEP LIMITED

(Exact Name as Specified in its Charter)

N/A

(Translation of Registrant’s Name)

Level 32, Australia Square

264 George Street, Sydney

NSW 2000, Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒   Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐   No ☒

If “Yes” is marked, indicated below the file number assigned to the registrant in connection with Rule 12g3-2(b): Not applicable.

EXHIBIT INDEX

Exhibit		Description of Exhibit
99.1		Immutep Receives A$4.6 million R&D Tax Incentive from French Government

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 03, 2025

IMMUTEP LIMITED
By:		/s/ Marc Voigt
Name:		Marc Voigt
Title:		Chief Executive Officer

FAQ

What did Immutep (IMMP) disclose in its latest 6-K?

Immutep reported receiving an A$4.6 million R&D tax incentive from the French Government.

How much is the French R&D tax incentive Immutep received?

The incentive totals A$4.6 million, as stated in the furnished exhibit.

Which government provided the R&D tax incentive to Immutep (IMMP)?

The French Government provided the R&D tax incentive.

Where in the filing is the incentive described?

In Exhibit 99.1 titled “Immutep Receives A$4.6 million R&D Tax Incentive from French Government.”

What is the form type for this disclosure from Immutep (IMMP)?

It is a Form 6-K furnished by Immutep Limited.